| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.098 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |